Insights

Strategic Partnerships SOMAÍ actively pursues and announces strategic partnerships with established cannabis brands (Jack Herer, Sherbinskis, Releaf Dispensary) and plans to expand global brand collaborations, presenting ongoing co-branding and distribution opportunities for sales teams.

EU-GMP Vertical As a leading EU-GMP vertically integrated MCO with a full European footprint and a Portuguese manufacturing facility, SOMAÍ offers end-to-end supply capabilities, enabling faster onboarding for new product lines and streamlined regulatory clearance for international buyers.

Expanded Product Line The launch of EU-GMP full-spectrum Essentials line extracts and a robust cannabis-based therapeutics pipeline indicate opportunities to cross-sell to existing distributors and health system partners seeking pharmaceutical-grade cannabinoid products.

Acquisition Momentum History of acquisitions (RPK Biopharma) and ongoing brand partnerships signal a growth trajectory and potential for channel expansion, channel financing discussions, and co-development arrangements with distributors and retail networks.

Global Reach With global sales teams targeting major medical cannabis markets and a multi-country footprint, there are scalable opportunities for regionality-focused pilots, contract manufacturing collaborations, and long-term supply agreements to satisfy diverse market needs.

Similar companies to SOMAÍ

SOMAÍ Tech Stack

SOMAÍ uses 8 technology products and services including Hotjar, WordPress, SAP, and more. Explore SOMAÍ's tech stack below.

Media & News

SOMAÍ's Email Address Formats

SOMAÍ uses at least 3 email formats:
SOMAÍ Email FormatsExamplePercentage
FL@somaipharma.euJD@somaipharma.eu
92%
LF@somaipharma.euDJ@somaipharma.eu
5%
First.Last@somaipharma.euJohn.Doe@somaipharma.eu
3%

Frequently Asked Questions

What is SOMAÍ's official website and social media links?

Minus sign iconPlus sign icon
SOMAÍ's official website is somaipharma.eu and has social profiles on LinkedIn and Crunchbase.

How much revenue does SOMAÍ generate?

Minus sign iconPlus sign icon
As of October 2026, SOMAÍ's annual revenue is estimated to be $1M - $10M.

What is SOMAÍ's NAICS code?

Minus sign iconPlus sign icon
SOMAÍ's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SOMAÍ have currently?

Minus sign iconPlus sign icon
As of October 2026, SOMAÍ has approximately 65 employees across 5 continents, including Europe, Oceania and Asia. Key team members include Founder, Bod, I-Ceo: M. S., Co-Founder Somai Pharmaceuticals: G. B. and Grow & Production Director: N. G. Explore SOMAÍ's employee directory with LeadIQ.

What industry does SOMAÍ belong to?

Minus sign iconPlus sign icon
SOMAÍ operates in the Pharmaceutical Manufacturing industry.

What technology does SOMAÍ use?

Minus sign iconPlus sign icon
SOMAÍ's tech stack includes Hotjar, WordPress, SAP, Shopify, Google Workspace, Notion, Adobe Creative Suite and DigitalOcean Web Hosting.

What is SOMAÍ's email format?

Minus sign iconPlus sign icon
SOMAÍ's email format typically follows the pattern of FL@somaipharma.eu. Find more SOMAÍ email formats with LeadIQ.

How much funding has SOMAÍ raised to date?

Minus sign iconPlus sign icon
As of October 2026, SOMAÍ has raised $42M in funding. The last funding round occurred on May 01, 2025 for $2.8M.

When was SOMAÍ founded?

Minus sign iconPlus sign icon
SOMAÍ was founded in 2019.
SOMAÍ logo

SOMAÍ

Pharmaceutical ManufacturingLisbon, Portugal51-200 Employees

SOMAÍ operates as a European-led, vertically integrated pharmaceutical company focused on cannabinoid-containing therapeutics and extracts, supported by EU-GMP certification and a multi-country distribution footprint. With a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, it coordinates global distribution through sales teams targeting the largest medical cannabis markets. Headquartered in Lisbon, in the Lisbon Region of Portugal, the company serves healthcare providers and distributors with pharmaceutical-grade cannabis products.

Ongoing strategic activities include acquisitions and partnerships intended to strengthen its European base and global reach. In February 2025, SOMAÍ launched an EU-GMP full-spectrum Essentials line of extracts, reflecting a concrete product development in its portfolio.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $42M

    SOMAÍ has raised a total of $42M of funding over 7 rounds. Their latest funding round was raised on May 01, 2025 in the amount of $2.8M as a Series C.

  • $1M - $10M

    SOMAÍ's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.